Aspirin 81 mg
- Product NDC
- 55681-402
- Requested package NDC
- 55681-402-03
- 11-digit product format
- 556810402
- Labeler code
- 55681
- Product ID
- 55681-402_f0398170-c8fd-4dcc-e053-2995a90a1c93
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin Enteric Coated Tablets 81 mg
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- TWIN MED LLC
- Application
- part343
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-11-01
- Marketing end
- 0000-00-00
- Substance
- ASPIRIN
- Active strength
- 81 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55681-402 | 55681-402-03 | D | Discontinued by firm | 2026-10-05 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 55681-402-03 | 55681040203 | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (55681-402-03) | 2022-11-01 | 0000-00-00 | No | No | Current |